French pharmaceutical company said drug could treat COVID-19 patients after promising test results
A leading French pharmaceutical company said it could potentially treat 300,000 COVID-19 patients with the anti-malarial drug Plaquenil after what it described as “promising” test results.
Sanofi said it was ready to offer France millions of doses of Plaquenil, a spokesperson for the laboratory told AFP, adding that the group was ready to work with French health authorities “to confirm these results.”
The study on 24 patients with coronavirus using Plaquenil, a hydroxychloroquine molecule, which has also been used for decades for the treatment of autoimmune diseases like lupus or rheumatoid arthritis.
Six days after the start of taking Plaquenil, the virus had disappeared in three-quarters of those treated, said Professor Didier Raoult, who is director of the Institut Hospitalo-Universitaire de Marseille.
The French government said the clinical trials were “promising” and would be extended to more patients.
You may be interested
Coronavirus Greece: 342 new cases & 9 fatalitiesPanos - Sep 25, 2020
The Greek competent authorities announced today 342 new cases of coronavirus in the country, of which 24 are associated with…
Weather forecast: CloudyPanos - Sep 25, 2020
Clouds, rain and winds from variable directions are forecast for Friday. Wind velocity will reach 6 on the Beaufort scale.…